Skip to main content

FACESURGICAL

Mid-Facelift in Murrieta

A mid-facelift is a surgical procedure that repositions the descended soft tissue of the cheek, principally the malar fat pad and the deeper midfacial layers, upward over the cheekbone. It addresses flattening of the cheek, hollowing where the lower eyelid meets the cheek, and deepening of the nasolabial fold. The lift is carried along a vertical or superolateral vector across the midface, a different direction from the cervicofacial facelift's vector toward the jawline and neck, so the two operations treat separate zones and are frequently planned in combination.

Dr. Vishal Banthia · Founder & Facial Plastic Surgeon

Woman in her forties laughing openly with her head tipped back, lit by broad soft daylight against a pale greige wall.

At a Glance

Midface lifting is commonly combined with lower eyelid surgery, where elevating the midface supports the lower lid and reduces the risk of postoperative ectropion[1]
Endoscopic subperiosteal fixation commonly uses absorbable polylactic-polyglycolic acid implants that dissolve over approximately 6 to 8 months[1]
Permanent facial nerve injury after midface lifting is reported in fewer than 1% of cases, with temporary weakness reported in up to 2.6%[1]
Deep nasolabial folds or significant malar fat descent are the findings that indicate adding a midface lift or a deep plane technique to a facelift[2]

Overview

Midfacial aging is driven by descent of the malar fat pad off the cheekbone. As the pad moves downward and toward the nose, the cheek loses projection, the distance between the lower eyelid and cheek lengthens, and soft tissue collects above the nasolabial fold. A mid-facelift releases the retaining ligaments holding the pad in its descended position and suspends it over the malar eminence. The correction comes from restoring position rather than adding volume.

Three surgical approaches are commonly used. The subciliary approach enters through an incision just beneath the lash line that extends 7 to 10 mm beyond the outer corner of the eye. The midface is then elevated vertically to the orbital rim or superolaterally to the deep temporal fascia.

The endoscopic subperiosteal approach uses small temporal and intraoral incisions. The elevated tissue is often anchored with an absorbable polylactic-polyglycolic acid implant that dissolves over approximately 6 to 8 months. The transtemporal deep plane approach uses a conventional preauricular incision, continues beneath the SMAS, and suspends the malar fat pad with absorbable sutures.

A midface lift is often part of a larger operation. It is commonly combined with a brow lift through the same endoscopic access. It is also combined with lower eyelid surgery, where elevation of the midface supports the lower lid and reduces the risk of postoperative ectropion.

A standard SMAS facelift is directed toward the lower face and neck. When deep nasolabial folds or significant malar descent are present, the indicated addition is a deep plane rhytidectomy or an adjunctive midface lift.

What to expect

  1. Consultation with facial analysis and photography, assessing malar projection, the lid-cheek junction, nasolabial fold depth, and lower eyelid support
  2. Preoperative medical evaluation, including review of medications that affect bleeding
  3. Administration of general anesthesia, or local anesthesia with sedation for a limited approach
  4. Marking of the selected access points (subciliary, temporal and intraoral endoscopic, or preauricular)
  5. Incision and elevation of the plane beneath the descended midfacial tissue, either subperiosteal over the maxilla or deep to the SMAS
  6. Release of the retaining ligaments tethering the malar fat pad
  7. Vertical or superolateral suspension of the malar fat pad, fixed with sutures to periosteum or deep temporal fascia, or with an absorbable implant
  8. Assessment of symmetry, cheek projection, and lower eyelid position with the head elevated
  9. Conservative trimming of redundant skin where the approach allows, keeping tension off the lower eyelid
  10. Layered closure, with drain placement when the dissection has been wide
  11. Application of a compressive dressing and review of postoperative instructions

How a mid-facelift works

  • The midface consists of skin, subcutaneous fat, the superficial muscular aponeurotic system, or SMAS, and deeper fascia over the maxilla. With age, the malar fat pad within these layers descends inferomedially off the cheekbone. The cheek flattens, and soft tissue gathers above the fixed dermal attachments of the perioral muscles, deepening the nasolabial fold.
  • Dissection proceeds beneath the descended tissue, either in a subperiosteal plane over the maxilla or deep to the SMAS. This approaches the malar fat pad together with its overlying soft tissue.
  • The retaining ligaments tethering the malar fat pad in its descended position are released. Without this release, the pad cannot travel and suspension sutures pull against a fixed attachment.
  • The mobilized tissue is lifted vertically or superolaterally. It is fixed to a stable anchor at the periosteum of the orbital rim, the deep temporal fascia, or an absorbable implant seated in bone. Fixation maintains the new position while scar tissue matures around the attachment.
  • The operation moves the patient's own tissue back over the malar eminence. Cheek projection is restored, and the nasolabial fold softens through repositioning. Skin excision has a secondary role.
  • A midface lift and a lower-face lift travel in different directions and address different zones. The choice depends on where the descent sits. Dr. Banthia examines the cheek, jawline, and neck together and will say when a midface lift alone would leave the jawline untouched. When both operations are indicated, they are usually planned as a single procedure.

When it's recommended

  • Descent of the malar fat pad producing flattening or loss of projection in the cheek
  • Deepening of the nasolabial fold caused by midfacial soft tissue descent
  • A lengthened lid-cheek junction with hollowing beneath the lower eyelid
  • Festoons or malar mounds being addressed alongside lower eyelid surgery
  • Midface support at the time of lower blepharoplasty to reduce the risk of eyelid malposition
  • Midfacial asymmetry
  • Midfacial descent in a patient whose jawline and neck do not yet warrant a full facelift

Is a mid-facelift right for you?

Reach out to learn more from Dr. Vishal Banthia.

Recovery & aftercare

  • A compressive dressing is typically worn for about 24 hours after surgery
  • Drains, when placed, are usually removed at the first dressing change on the day after surgery
  • Sutures are typically removed at about one week
  • Midfacial swelling lasts longer than after a skin-and-SMAS facelift, and subperiosteal dissection can leave visible fullness for several weeks
  • Sleeping with the head elevated helps limit swelling during early healing
  • Strenuous activity and heavy lifting are typically restricted for approximately 4 weeks
  • Follow-up visits are typically scheduled at one month for wound evaluation and at three months for photography
  • Final cheek contour settles over several months as swelling resolves and fixation matures

Alternatives

  • Deep plane facelift, which addresses the midface and lower face through a single dissection
  • Cervicofacial rhytidectomy (SMAS facelift) when the jawline and neck are the dominant concern
  • Facial fat grafting to restore malar volume without repositioning tissue
  • Injectable soft tissue fillers for temporary midface volume
  • Lower eyelid blepharoplasty with fat repositioning when the tear trough is the isolated finding
  • Suture suspension (thread) techniques for mild descent

Related treatments

Frequently Asked Questions

  • A mid-facelift lifts descended cheek tissue back over the cheekbone. It addresses the area between the lower eyelid and the corner of the mouth, including a flattened cheek, hollowing beneath the eye, and a deepening nasolabial fold.
  • The operations treat different zones along different vectors. A cervicofacial facelift lifts toward the jawline and neck to address jowls and neck laxity. A mid-facelift lifts the malar fat pad vertically or superolaterally across the cheek. Dr. Banthia determines which zone is driving what a patient sees in the mirror, since a lift aimed at the wrong area disappoints even when it is done well. When both zones show descent, the procedures are often combined, or a deep plane facelift may be selected to reach the midface through one dissection.
  • Incision placement depends on the approach. A subciliary approach uses an incision just below the lash line that extends slightly beyond the outer corner of the eye. An endoscopic subperiosteal approach uses small incisions in the temporal hair-bearing scalp and inside the upper lip. A transtemporal deep plane approach uses a conventional preauricular facelift incision.
  • A compressive dressing is typically worn for about one day, and sutures are removed at roughly one week. Strenuous activity is usually restricted for about four weeks. Midfacial swelling lasts longer than swelling after a traditional facelift, particularly when subperiosteal dissection is used. Final cheek contour settles over several months.
  • Midface lifting is a well-described procedure with reported complication rates in line with other facial surgery. Permanent facial nerve injury is reported in fewer than 1% of cases, and temporary weakness is reported in up to 2.6%. Ectropion, hematoma, prolonged swelling, and asymmetry are also recognized complications. A surgeon reviews each of these during consultation.
  • Midface lifting is generally deferred for patients who use nicotine, have an unmanaged bleeding disorder, take anticoagulation without medical clearance, have uncontrolled diabetes or another condition that impairs healing, have received radiation to the facial soft tissues, or carry elevated cardiopulmonary risk for elective general anesthesia. Patients whose concern is confined to the jawline and neck are typically better served by a different operation.
  • Not exactly. Filler adds material to a cheek that has lost volume, while a midface lift returns a descended cheek pad to its earlier position. A face can need one, the other, or both. Dr. Banthia does not offer filler or other cosmetic injectables; his menu is surgical. If added volume is the appropriate treatment, he will say so rather than steer the patient toward an operation. Facial fat transfer is the volume option he performs, using the patient's own tissue.
  • Consultations for mid-facelift are available at Dr. Banthia's Murrieta office (39755 Date St, Suite 105, Murrieta, CA 92563); Dr. Banthia's Carlsbad office (2390 Faraday Ave, Carlsbad, CA 92008). Contact the office to schedule an appointment at the location most convenient for you.

Mid-Facelift risks & candidacy

Who should avoid this

  • Bleeding disorders or anticoagulant therapy without medical clearance
  • Active tobacco or nicotine use, which impairs flap healing
  • Uncontrolled diabetes or another condition that impairs wound healing
  • Prior radiation therapy to the facial soft tissues
  • Active infection at or near the planned incision sites
  • Elevated cardiopulmonary risk for elective surgery under general anesthesia
  • Goals that the operation cannot meet, identified during consultation

Possible risks

  • Temporary weakness of a facial nerve branch, reported in up to 2.6% of cases
  • Permanent facial nerve injury, reported in fewer than 1% of cases
  • Hematoma, which may require drainage and is more frequent in male patients
  • Seroma at the dissection site
  • Lower eyelid malposition, scleral show, or ectropion following a subciliary approach
  • Prolonged midfacial swelling, which is characteristic of subperiosteal dissection and can remain visible for weeks
  • Asymmetry, undercorrection, or early loss of suspension
  • Wound infection
  • Skin flap necrosis, with elevated risk in patients who use nicotine
  • Visible or hypertrophic scarring at the subciliary or temporal incision
  • Numbness or altered sensation across the cheek from infraorbital nerve irritation
  • Dissatisfaction with the aesthetic result, which is the most frequently reported complication

Your practitioner

Dr. Vishal Banthia

Dr. Vishal Banthia, MD, FACS

Dr. Vishal Banthia is a double board-certified facial plastic surgeon practicing in Murrieta and Carlsbad, California. He is certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology-Head and Neck Surgery, and is a Fellow of the American College of Surgeons. His practice is surgical and face-only: facelift, neck lift, eyelid surgery, and rhinoplasty. He lectures internationally, has published peer-reviewed research indexed in the National Library of Medicine, and received the American Academy of Otolaryngology's Humanitarian Travel Award for cleft lip and palate surgery in Honduras.

Medically reviewed by Dr. Vishal Banthia, MD, FACS · Last reviewed: 2026-09-22